bioRxivSynthetic BiologyPreprint
Design of a Soluble Multivalent Notch Agonist
Rubul MoutiD, Ran Jing, Emily D. EganiD, Helen E. EisenachiD, Mohamad Ali Toufic NajiaiD, Luca T. Hensch, Trevor BinghamiD, Martin A. Kononov, Rajesh D. GunageiD, Yunliang Zhao, Natasha I. EdmaniD, Thorsten M. SchlaegeriD, Leonard Ira ZoniD, Trista E. NorthiD, Urban LendahliD, David A. BakeriD, Stephen C. BlacklowiD, George Q. DaleyiD
Abstract
Designed protein agonists can enhance the efficiency of endogenous signaling pathways, and provide a powerful means to control cellular functions and develop disease therapeutics. Designing a soluble cytokine-like agonist for Notch signaling, an evolutionarily conserved pathway that regulates cell fate in embryonic and adult development, is especially challenging because Notch receptor activation requires a mechanical force that is typically mediated by cell-associated transmembrane ligands at sites of cell-cell contact. Moreover, free soluble Notch ligand is signal inhibitory. Here, we exploit computationally designed protein oligomers with precise geometries and valencies to generate cytokine-like, protein only, multivalent soluble Notch agonists. These tools promote cell-cell contact, cluster Notch proteins in synapses at the cell surface, and activate Notch signaling in reporter cell lines and cells expressing endogenous receptors. We demonstrate the utility of these soluble Notch agonists in T cell differentiation from cord blood (CB) and human induced pluripotent stem cells (iPSCs), and in bioreactor production of T cells in liquid suspension. Soluble multivalent Notch agonists can be applied broadly to in vitro cellular differentiation methods to generate clinical cell products and to develop immunotherapies.
- organism: human
- assay: protein structure
- research focus: drug response / drug discovery
- approach: experimental assay
- Citations
- 4
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Engineering synthetic agonists for targeted activation of Notch signaling
David H. Perez, Daniel Antfolk, … Vincent C. Luca·Nature Chemical BiologyPeer-reviewed·Sep 24, 2025
- Notch engagement by Jag1 nanoscale clusters indicates a force-independent mode of activation
I. Smyrlaki, F. Fördös, … B. Högberg·bioRxiv·Nov 22, 2022
- An affinity-matured DLL4 ligand for broad-spectrum activation and inhibition of Notch signaling
D. Gonzalez-Perez, S. Das, … V. C. Luca·bioRxiv·Mar 7, 2022
- Tuning of granulopoietic signaling by de novo designed agonists
T. Ullrich, C. Pollmann, … M. ElGamacy·bioRxiv·Nov 25, 2023
- High-Throughput De Novo Protein Design Yields Novel Immunomodulatory Agonists
Mohamad H. Abedi, Marc Expòsit, … David A. Baker·bioRxiv·Oct 12, 2025
- Engineered Receptors for Soluble Cell-to-Cell Communication
Dan Ilya Piraner, Mohamad H. Abedi, … Kole T. Roybal·NaturePeer-reviewed·Nov 14, 2024